{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:28:32Z","timestamp":1790382512455,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG1788"],"award-info":[{"award-number":["PRG1788"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["EAG79"],"award-info":[{"award-number":["EAG79"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Estonian Research Council","doi-asserted-by":"publisher","award":["PRG230"],"award-info":[{"award-number":["PRG230"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["355520"],"award-info":[{"award-number":["355520"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentariumin Tiedes\u00e4\u00e4ti\u00f6 sr","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018225","name":"EuroNanoMed III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010128","name":"Lasten Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6 V\u00e4reen","doi-asserted-by":"publisher","award":["202100016"],"award-info":[{"award-number":["202100016"]}],"id":[{"id":"10.13039\/100010128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejps.2024.106866","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:40:34Z","timestamp":1721986834000},"page":"106866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PL3 CendR peptide shows specific uptake in cultured Y79 retinoblastoma cells with nucleolar accumulation"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9353-6802","authenticated-orcid":false,"given":"Sonja","family":"Korhonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stef","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antero","family":"Erkinheimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatu","family":"Lajunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Rilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambet","family":"Teesalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Subrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106866_bib0001","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","article-title":"Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds","volume":"103","author":"Abramson","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2024.106866_bib0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2024.106866_bib0003","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2112457118","article-title":"A widespread viral entry mechanism: the C-end Rule motif\u2013neuropilin receptor interaction","volume":"118","author":"Balistreri","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2024.106866_bib0004","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1167\/iovs.08-2356","article-title":"Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry","volume":"50","author":"Balla","year":"2009","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jconrel.2020.09.005","article-title":"Release of functional dexamethasone by intracellular enzymes: a modular peptide-based strategy for ocular drug delivery","volume":"327","author":"Bhattacharya","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2024.106866_bib0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00418-014-1285-z","article-title":"Re-characterization of established human retinoblastoma cell lines","volume":"143","author":"Busch","year":"2015","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejps.2024.106866_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151235","article-title":"Microscopic characterization reveals the diversity of EVs secreted by GFP-HAS3 expressing MCF7 cells","volume":"101","author":"Capra","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejps.2024.106866_bib0008","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12885-018-4406-6","article-title":"Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2024.106866_bib0009","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)64653-6","article-title":"Metastatic and nonmetastatic models of retinoblastoma","volume":"157","author":"Ch\u00e9vez-Barrios","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2024.106866_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(22)00167-4","article-title":"Dual \u03b1V-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study","volume":"7","author":"Dean","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2024.106866_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2024.106866_bib0012","first-page":"3336","article-title":"Transplantation of Y79 cells into rat eyes: an in vivo model of human retinoblastomas","volume":"34","author":"del Cerro","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0013","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Primer"},{"key":"10.1016\/j.ejps.2024.106866_bib0014","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2024.106866_bib0015","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41388-017-0050-x","article-title":"The management of retinoblastoma","volume":"37","author":"Fabian","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2024.106866_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41433-018-0244-7","article-title":"Retinoblastoma in Asia","volume":"33","author":"Jain","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.ejps.2024.106866_bib0017","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death","volume":"93","author":"Kivela","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2024.106866_bib0018","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fgene.2020.00142","article-title":"Spectrum of RB1 germline mutations and clinical features in unrelated chinese patients with retinoblastoma","volume":"11","author":"Lan","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejps.2024.106866_bib0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1110\/ps.03498604","article-title":"Trypsin specificity as elucidated by LIE calculations, X-ray structures, and association constant measurements","volume":"13","author":"Leiros","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0021","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1038\/s41598-020-62760-y","article-title":"Tumor-penetrating peptide for systemic targeting of Tenascin-C","volume":"10","author":"Lingasamy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2024.106866_bib0022","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.febslet.2006.01.064","article-title":"Mapping nucleolar localization sequences of 1A6\/DRIM","volume":"580","author":"Liu","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2024.106866_bib0023","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2174\/1389557515666150722100610","article-title":"Progress in small molecule therapeutics for the treatment of retinoblastoma","volume":"16","author":"M. Pritchard","year":"2016","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106866_bib0024","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/19491034.2015.1079680","article-title":"Principles of protein targeting to the nucleolus","volume":"6","author":"Martin","year":"2015","journal-title":"Nucleus"},{"key":"10.1016\/j.ejps.2024.106866_bib0025","unstructured":"McFall, R.C., Sery, W., Makadon, M., 1977. Characterization of a New Continuous Cell Line Derived from a Human Retinoblastoma."},{"key":"10.1016\/j.ejps.2024.106866_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.05.005","article-title":"Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. \u201cAlive, with good vision and no comorbidity","volume":"73","author":"Munier","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2024.106866_bib0027","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12885-017-3750-2","article-title":"In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line","volume":"17","author":"Nair","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2024.106866_bib0028","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2013.12.006","article-title":"A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity","volume":"175","author":"Pang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2024.106866_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32844","article-title":"Retinoblastoma: an update on genetic origin, classification, conventional to next-generation treatment strategies","volume":"10","author":"Pareek","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejps.2024.106866_bib0030","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3390\/cells11162573","article-title":"Intraocular RGD-engineered exosomes and active targeting of choroidal neovascularization (CNV)","volume":"11","author":"Pollalis","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2024.106866_bib0031","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1042\/BST0350788","article-title":"Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells","volume":"35","author":"Poon","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejps.2024.106866_bib0032","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jconrel.2023.07.025","article-title":"Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice","volume":"360","author":"Puranen","year":"2023","journal-title":"J. Controll. Release"},{"key":"10.1016\/j.ejps.2024.106866_bib0033","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jnci\/53.2.347","article-title":"Characteristics of an established cell line of retinoblastoma","volume":"53","author":"Reid","year":"1974","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejps.2024.106866_bib0034","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(97)00824-7","article-title":"Mutational analysis of human prothymosin \u03b1 reveals a bipartite nuclear localization signal","volume":"413","author":"Rubtsov","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2024.106866_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","article-title":"Tumor penetrating peptides for improved drug delivery","volume":"110\u2013111","author":"Ruoslahti","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106866_bib0036","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.12-9501","article-title":"Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients","volume":"53","author":"Schaiquevich","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0037","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/jb.124.3.1598-1600.1975","article-title":"Ultrastructural visualization of surface carbohydrate structures on mycoplasma membranes by concanavalin A","volume":"124","author":"Schiefer","year":"1975","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ejps.2024.106866_bib0038","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejps.2024.106866_bib0039","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1093\/nar\/gkq653","article-title":"Characterization and prediction of protein nucleolar localization sequences","volume":"38","author":"Scott","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2024.106866_bib0040","first-page":"1548","article-title":"Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre","volume":"104","author":"Shields","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejps.2024.106866_bib0041","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201980119","article-title":"ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1","volume":"119","author":"Simonetti","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0042","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2024.106866_bib0043","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2009.10.013","article-title":"Tissue-penetrating delivery of compounds and nanoparticles into tumors","volume":"16","author":"Sugahara","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2024.106866_bib0044","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejps.2024.106866_bib0045","doi-asserted-by":"crossref","first-page":"16157","DOI":"10.1073\/pnas.0908201106","article-title":"C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration","volume":"106","author":"Teesalu","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2024.106866_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00216","article-title":"Tumor-penetrating peptides","volume":"3","author":"Teesalu","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2024.106866_bib0047","doi-asserted-by":"crossref","first-page":"23776","DOI":"10.1016\/S0021-9258(17)31583-1","article-title":"Identification of the nuclear and nucleolar localization signals of the protein p120. Interaction with translocation protein B23","volume":"269","author":"Valdez","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106866_bib0048","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.febslet.2007.05.082","article-title":"The maximal size of protein to diffuse through the nuclear pore is larger than 60 kDa","volume":"581","author":"Wang","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2024.106866_bib0049","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature10733","article-title":"A novel retinoblastoma therapy from genomic and epigenetic analyses","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:17:24Z","timestamp":1778775444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S0928098724001787"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106866","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PL3 CendR peptide shows specific uptake in cultured Y79 retinoblastoma cells with nucleolar accumulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106866"}}